Mesothelioma (from page 2)

References

  1. Hammar SP. Pleural diseases. In: Pulmonary Pathology, 2nd Ed. Dail DH, Hammar SP (Eds). New York: Springer-Verlag Inc, 1994:1487-1579.
  2. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC. Malignant epithelioid pleural mesothelioma versus peripheral adenocarcinoma: a histochemical, ultrastructural and immunohistologic study of 103 cases. Hum Pathol 1990; 21:759-766.Benjamin CJ, Ritchie AC. Histological staining for the diagnosis of mesothelioma. Am J Med Technol 1982: 48:905-908.Ernst CS, Atkinson BF. Mucicarmine positivity in malignant mesothelioma. Lab Invest 1980: 42:113-114.
  3. MacDougall DB, Wang SE, Zibar BL. Mucin-positive epithelial mesothelioma. Arch Path Lab Med 1992:116:874-880.Merger J, Lamerz R, Permanether W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorac Cardiovasc Surg 1990: 100:860-866.
  4. Otis CN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma: a bi-institutional study of 47 cases. Am J Surg Pathol 1987:11:445-456.
  5. Robb JA. Mesothelioma versus adenocarcinoma: false positive CEA and LeuM1 staining due to hyaluronic acid. Hum Pathol 1989:20:400.
  6. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shuh AR, Wick MR. Immunoreactivity for BerEP4 in adenocarcinoma, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 1992:16:593-599.
  7. Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol 1976:65:159-167.
  8. Koss M, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol 1992:9:117-123.
  9. Robb JA, Hammar SP, Yokoo H. Pseudomesotheliomatous lung carcinoma: a rare asbestos-related malignancy readily separable from epithelial pleural mesothelioma. Hum Pathol, in press.Hammar SP. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms. In: MacKay B (Ed). Diagnostic Electron Microscopy of Tumors. New York: W.B. Saunders. 1987:1-230.
  10. Henderson DW, Papadimitriou JM, Coleman M. Ultrastructural Appearances of Tumors. 2nd Edition. Edinburgh: Churchill Livingstone. 1986:42-112.
  11. Burns TR, Johnson EH, Cartwright J Jr, Greenberg SD. Desmosomes of epithelial malignant mesotheliomas. Ultra Pathol 1988:12:385-388.
  12. Dewar A. Valente M, Ring NP, Corrin B. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol 1987:152:309-316.Coleman M, Henderson DW, Mukherjee TM. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu 1989;24:303-353.
  13. Ghadially FN, McCaughey WTE, Perkins DG, Rippstein P. Diagnostic value of microvillus-matrix associations in tumors. J Submicrosc Cytol Pathol 1992;24:103-108.
  14. Ghadially FN, McCaughey WTE, Perkins DG, Rippstein P, Jeans D. Morphogenesis and frequency of microvillus-matrix associations in mesotheliomas and adenocarcinomas. MSA Bulletin 1993:23:281-287.Ghadially FN. Diagnostic value of some matrix components. Ultrastruct Pathol 1992:16:221-230.Graeme-Cook, F, Mark EJ. Pulmonary mucinous cystic tumors of borderline malignancy. Hum Pathol 1991:22:185-190.
  15. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP (eds). Pulmonary Pathology, 2nd Ed. New York: Springer-Verlag Inc, 1994:1123-1278.
  16. Albernet R, Jageux M, Fondimare A, et al. Les mesotheliomes pleuraux. Rev fr Mal Resp 1979:7:243-264.Culling DFA, Reid PE, Burton JD, et al. A histochemical method of differentiating lower gastrointestinal tract tumors. J Clin Pathol 1975;28:656-658.
  17. Henderson DW, Shilkin KB, Whitaker D, Atwood HD, Constance TJ, Steele RH, Leppard PJ. The pathology of malignant mesothelioma, including immunohistology and ultrastructure. In: Henderson DW, Shilkin KG, Langlois SLD, Whitaker D (Eds). Malignant Mesothelioma. New York: Hemisphere. 1992:69-139.
  18. Walz R, Koch HK. Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and followup of mesotheliomas diagnosed from 1964 to January 1985. Pathol Res Prac 1990:186:124-134.
  19. Roggli VL, Kolbeck J, Sanfilippo F, Shelburne JD. Pathology of human mesothelioma: etiology and diagnostic considerations. Pathol Annu 1987:22(part 2):91-131.
  20. Brown RW, Clark CM, Tandon AK, Allread DC. Multiple-marker immunohistochemical phenotype distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993:24:347-354.
  21. Loosli H, Hurlimann J. Immunohistological study of malignant diffuse mesothelioma of the pleura. Histopathol 1984:8:793-803.
  22. Iozzo RV, Goldes JA, Chen W-J, Wight TN. Glycosaminoglycans of pleural mesothelioma: a possible biochemical variant containing chondroitin sulfate.-Cancer 1981:48:89-97.
  23. Nakano T, Fujii J, Tamura S, et al. Glycosaminoglycan in malignant pleural mesothelioma. Cancer 1986:57:106-110.Waxler B, Eisenstein R, Battifora H. Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesothelioma. Cancer 1979:44:221-227.
  24. Yung S, Thomas GJ, Stylianov E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans: human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995:146:520-529.
  25. Sandell LJ. Molecular biology of proteoglycans and link proteins. In: Wight TN, Mecham RP (Eds). Biology of Proteoglycans. Orlando: Academic Press. 1987:27-57.
  26. Caterson B, Calabro T, Hampton A. Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Wight TN, Mecham RP (Eds). Biology of Proteoglycans. Orlando: Academic Press. 1987:1-25.Holland ND, Holland LZ. Fine structures of the mesothelia and extracellular materials in the coelomic fluid of fin boxes, myocoels and sclerocoels of a lancet, Branchiostoma f1oridae (Cephalochordata = Acrania). Acta Zoologica (Stockholm) 1990: 71:225-234.
  27. Henderson DW. Leppard PJ, Howard MJ. The diagnostic fine structure of malignant mesothelioma. Proceedings of the World Health Organization Bi-Regional Training Course of Electron Microscopy in BioMedical Research and Diagnosis of Human Diseases. Bangkok, Thailand, 28 October - 1 November, 1991.
  28. Kawai T, Suzuki M, Kageyama K. Glycosaminoglycans in lung carcinoma. Hum Pathol 1988:1288-1292.Hammar SP, Bockus D, Remington F, Bartha M: The widespread distribution of Langerhans cells in pathologic tissue: An ultrastructural and immunohistochemical study. Hum Pathol 1986:17:894-905.
  29. Friedman HD, Litovsky SH, Abraham JL. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma. Arch Pathol Lab Med 1993:117:967.

Newsletter

Home Page